Related Experiment Videos
1,3-Butadiene: exposure estimation, hazard characterization, and exposure-response analysis
1Existing Substances Division, Environmental Health Directorate, Health Canada, Environmental Health Centre, Tunney's Pasture PL0802B1, Ottawa, Ontario, Canada K1A 0L2.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews
|February 18, 2003
Summary
1,3-Butadiene is a probable human carcinogen and genotoxin, posing risks through ambient air exposure. Studies show it causes tumors and reproductive harm in animals, with potential human health impacts.
Area of Science:
- Environmental Health
- Toxicology
- Occupational Health
Background:
- 1,3-Butadiene is a priority substance in Canada, with general population exposure mainly via ambient air.
- Inhalation of 1,3-butadiene is carcinogenic in rodents, inducing tumors and genotoxicity.
- Occupational exposure is linked to leukemia, and limited evidence suggests genotoxicity in workers.
Purpose of the Study:
- To assess the carcinogenic and genotoxic potential of 1,3-butadiene in humans based on available data.
- To estimate the potency of 1,3-butadiene for inducing cancer and reproductive effects.
- To identify and address uncertainties, including species-specific metabolic differences and genetic polymorphisms.
Main Methods:
- Review of epidemiological investigations and toxicological bioassays in mice and rats.
- Analysis of studies on reproductive effects in female mice.
- Consideration of species differences in metabolism and human metabolic variability.
Main Results:
- 1,3-Butadiene is highly likely to be carcinogenic and likely to be genotoxic in humans.
- Mice exhibit greater sensitivity to 1,3-butadiene's effects than rats, likely due to metabolic differences.
- Cancer and ovarian effect potencies were estimated, incorporating conservative approaches due to metabolic uncertainties.
Conclusions:
- The weight of evidence indicates 1,3-butadiene poses significant health risks, including cancer and genotoxicity, to humans.
- Species differences in metabolism necessitate conservative potency estimates for human risk assessment.
- Further research may be needed to fully elucidate the impact of genetic polymorphism on individual susceptibility.